NO20044996L - Furylforbindelser - Google Patents
FurylforbindelserInfo
- Publication number
- NO20044996L NO20044996L NO20044996A NO20044996A NO20044996L NO 20044996 L NO20044996 L NO 20044996L NO 20044996 A NO20044996 A NO 20044996A NO 20044996 A NO20044996 A NO 20044996A NO 20044996 L NO20044996 L NO 20044996L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- furylforbindelser
- compositions
- therapy
- pharmaceutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Forbindelser av formel (I) og farmasøytisk akseptable salter derav, hvor Ar og R er som definert i beskrivelsen, preparater som inneholder slike forbindelser og anvendelsen av slike forbindelser og preparater for bruk i terapi.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0201186A SE0201186D0 (sv) | 2002-04-18 | 2002-04-18 | Furyl compounds |
SE0203607A SE0203607D0 (sv) | 2002-12-04 | 2002-12-04 | Furyl compounds |
PCT/SE2003/000613 WO2003087102A1 (en) | 2002-04-18 | 2003-04-15 | Furyl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044996L true NO20044996L (no) | 2005-01-18 |
Family
ID=29253788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044996A NO20044996L (no) | 2002-04-18 | 2004-11-17 | Furylforbindelser |
Country Status (16)
Country | Link |
---|---|
US (1) | US7417049B2 (no) |
EP (1) | EP1499618B1 (no) |
JP (1) | JP4511195B2 (no) |
KR (1) | KR20040099447A (no) |
CN (1) | CN1325500C (no) |
AT (1) | ATE484508T1 (no) |
AU (1) | AU2003225456B2 (no) |
BR (1) | BR0309343A (no) |
CA (1) | CA2482311C (no) |
DE (1) | DE60334536D1 (no) |
HK (1) | HK1079519A1 (no) |
IL (1) | IL164509A0 (no) |
MX (1) | MXPA04010191A (no) |
NO (1) | NO20044996L (no) |
NZ (1) | NZ561794A (no) |
WO (1) | WO2003087102A1 (no) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
BR0213612A (pt) | 2001-10-02 | 2004-08-24 | Upjohn Co | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
JP4511196B2 (ja) * | 2002-04-18 | 2010-07-28 | アストラゼネカ・アクチエボラーグ | チエニル化合物 |
JP4855264B2 (ja) | 2003-10-21 | 2012-01-18 | アストラゼネカ・アクチエボラーグ | スピロフロピリジンアリール誘導体 |
US7045530B2 (en) | 2003-12-22 | 2006-05-16 | Abbott Laboratories | Spirocyclic quinuclidinic ether derivatives |
TW200813067A (en) * | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
AU2009260905B2 (en) | 2008-06-20 | 2012-08-23 | Astrazeneca Ab | Dibenzothiazepine derivatives and use thereof |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
PT3029039T (pt) | 2010-05-17 | 2017-11-28 | Forum Pharmaceuticals Inc | Formulações farmacêuticas que compreendem formas cristalinas de cloridrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida mono-hidratado |
RU2582339C2 (ru) | 2010-05-27 | 2016-04-27 | Таргасепт, Инк. | Неконкурентные антагонисты никотиновых рецепторов |
GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
JO3115B1 (ar) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
CA2872005A1 (en) | 2012-05-08 | 2013-11-14 | Forum Pharmaceuticals, Inc. | Methods of maintaining, treating or improving cognitive function |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
EP2953940B1 (en) | 2013-02-07 | 2018-08-22 | Heptares Therapeutics Limited | Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic m4 receptor agonists |
CN105324372B (zh) | 2013-06-21 | 2018-03-06 | 武田药品工业株式会社 | 作为前动力蛋白受体调节剂的1‑磺酰基哌啶衍生物 |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
GB201318222D0 (en) | 2013-10-15 | 2013-11-27 | Takeda Pharmaceutical | Novel compounds |
GB201320905D0 (en) | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
TW201613864A (en) | 2014-02-20 | 2016-04-16 | Takeda Pharmaceutical | Novel compounds |
WO2016073407A1 (en) * | 2014-11-04 | 2016-05-12 | Bristol-Myers Squibb Company | Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
GB201616839D0 (en) | 2016-10-04 | 2016-11-16 | Takeda Pharmaceutical Company Limited | Therapeutic compounds |
CN108003895B (zh) * | 2016-10-28 | 2019-04-19 | 西安近代化学研究所 | 一种向列相液晶组合物及其显示元件 |
CN108018049B (zh) * | 2016-10-28 | 2019-09-27 | 西安近代化学研究所 | 具有5,6-二氟取代苯并呋喃环的液晶化合物 |
GB201619514D0 (en) | 2016-11-18 | 2017-01-04 | Takeda Pharmaceuticals Co | Novel compounds |
US11771738B2 (en) | 2018-05-10 | 2023-10-03 | Zoetis Services Llc | Endoparasitic depsipeptides |
JP2021138648A (ja) | 2020-03-04 | 2021-09-16 | 武田薬品工業株式会社 | 経口固形製剤 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
FR2788982B1 (fr) * | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
US6569865B2 (en) * | 2001-06-01 | 2003-05-27 | Astrazeneca Ab | Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine |
MXPA03010996A (es) | 2001-06-01 | 2004-02-27 | Aztrazeneca Ab | Nuevo ligando para receptores nicotinicos de acetilcolina utiles en terapia. |
JP4511196B2 (ja) * | 2002-04-18 | 2010-07-28 | アストラゼネカ・アクチエボラーグ | チエニル化合物 |
-
2003
- 2003-04-15 JP JP2003584058A patent/JP4511195B2/ja not_active Expired - Fee Related
- 2003-04-15 AT AT03746523T patent/ATE484508T1/de not_active IP Right Cessation
- 2003-04-15 MX MXPA04010191A patent/MXPA04010191A/es active IP Right Grant
- 2003-04-15 KR KR10-2004-7016547A patent/KR20040099447A/ko not_active Application Discontinuation
- 2003-04-15 US US10/511,535 patent/US7417049B2/en not_active Expired - Fee Related
- 2003-04-15 AU AU2003225456A patent/AU2003225456B2/en not_active Ceased
- 2003-04-15 WO PCT/SE2003/000613 patent/WO2003087102A1/en active Application Filing
- 2003-04-15 EP EP03746523A patent/EP1499618B1/en not_active Expired - Lifetime
- 2003-04-15 CN CNB038138956A patent/CN1325500C/zh not_active Expired - Fee Related
- 2003-04-15 CA CA002482311A patent/CA2482311C/en not_active Expired - Fee Related
- 2003-04-15 NZ NZ561794A patent/NZ561794A/en unknown
- 2003-04-15 BR BR0309343-3A patent/BR0309343A/pt not_active IP Right Cessation
- 2003-04-15 DE DE60334536T patent/DE60334536D1/de not_active Expired - Lifetime
-
2004
- 2004-10-11 IL IL16450904A patent/IL164509A0/xx unknown
- 2004-11-17 NO NO20044996A patent/NO20044996L/no unknown
-
2005
- 2005-12-14 HK HK05111483A patent/HK1079519A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2482311C (en) | 2009-12-08 |
AU2003225456B2 (en) | 2009-02-05 |
DE60334536D1 (de) | 2010-11-25 |
CN1662541A (zh) | 2005-08-31 |
WO2003087102A1 (en) | 2003-10-23 |
JP2005533012A (ja) | 2005-11-04 |
MXPA04010191A (es) | 2005-02-03 |
AU2003225456A1 (en) | 2003-10-27 |
EP1499618B1 (en) | 2010-10-13 |
KR20040099447A (ko) | 2004-11-26 |
BR0309343A (pt) | 2005-02-15 |
NZ561794A (en) | 2008-11-28 |
US7417049B2 (en) | 2008-08-26 |
CA2482311A1 (en) | 2003-10-23 |
JP4511195B2 (ja) | 2010-07-28 |
HK1079519A1 (en) | 2006-04-07 |
EP1499618A1 (en) | 2005-01-26 |
ATE484508T1 (de) | 2010-10-15 |
IL164509A0 (en) | 2005-12-18 |
US20050176745A1 (en) | 2005-08-11 |
CN1325500C (zh) | 2007-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60334536D1 (de) | Furylverbindungen | |
NO20044995L (no) | Heterosykliske forbindelser | |
HK1079522A1 (en) | Thienyl compounds | |
SE0202463D0 (sv) | Novel compounds | |
IS7721A (is) | Píperidín-pýrídasón og þalasón sem PDE4 hemlar | |
SE0401971D0 (sv) | Piperidne derivatives | |
SE0101387D0 (sv) | Novel compounds | |
MX2007005933A (es) | Compuestos de acetamida como fungicidas. | |
CY1110498T1 (el) | Παραγωγα πυραζολης ως αναστολεις των κινασων τυροσινης υποδοχεα | |
SE0401970D0 (sv) | Novel compounds | |
ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
SE0203303D0 (sv) | Novel Compounds | |
SE0203300D0 (sv) | Novel Compounds | |
EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
SE0300105D0 (sv) | Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof | |
SE0203302D0 (sv) | Novel Compounds | |
DE60316128D1 (de) | N-sulfonylurea-apoptosis-förderer | |
DE602004018811D1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
NO20030500L (no) | Dihydroporfyrinderivater og deres anvendelse | |
MXPA06004299A (es) | Derivados de arilespirofuropiridina. | |
DK1638948T3 (da) | Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere | |
ATE416162T1 (de) | Naphthamidderivate und deren verwendung | |
IS8034A (is) | Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla | |
SE0203301D0 (sv) | Novel Compounds |